Another study finds no evidence of increased long-term mortality with paclitaxel-coated devices

This post was originally published on this site

Patients who underwent endovascular revascularization with a paclitaxel-based drug-eluting device did not have an increased mortality risk over an 11-year follow-up period, according to a safety analysis published in the European Heart Journal.

Click here to read full article